#41Official Top 100
Innovent Biologics
信达生物制药(苏州)有限公司
#41
BiologicsOncology, ADC and high-potency
Manufacturing profile
Biologics
Oncology, ADC and high-potency
Selection basis
The company is included in the official 2024 ranking of the 100 largest Chinese pharmaceutical-industry enterprises by main-business revenue.
The FUZKK fit shows potential applicability of existing utilities. It does not claim actual use of FUZKK, specific installed equipment models or a product not confirmed by the public company profile.
Representative manufacturing and QC chain
- 1Cell bank or microbial seed
- 2Upstream culture or fermentation
- 3Clarification and chromatography
- 4UF/DF, formulation and sterile filtration
- 5SEC, CE, LC-MS, ELISA, qPCR and bioassay QC
- 6Raw-material receipt and identification
- 7Dispensing, blending and granulation
- 8Tableting, encapsulation or solution preparation
- 9Packaging and labelling
Relevant FUZKK packages
Product/API utilities
Lumex — instrumental QC
LabEx — laboratory QC
Biologic Aggregate Size Quality CheckerCharge Variant CE Quality CheckerProtein Concentration UV Quality CheckerELISA Bioassay Quality CheckerSPR Binding Affinity Quality CheckerEndotoxin Biologic Product Quality CheckerAutomated Sterility Detection Quality CheckerAssay & Impurity HPLC Quality CheckerLC-MS Confirmation Quality CheckerSterility Test Membrane Filtration Quality Checker
Medical Devices — equipment and software lifecycle
Suggested first pilot
- Confirm one real product, method or recurring QC review.
- Record the instrument, export format and current specification.
- Select 3–7 utilities from the map above.
- Run a PASS/FAIL sample and agree the expected output.
- After user validation, expand the scope.
Mapping boundary
The FUZKK fit shows potential applicability of existing utilities. It does not claim actual use of FUZKK, specific installed equipment models or a product not confirmed by the public company profile.
Methodology